![]() Read the full story by clicking on this headline.. |
Amylyx Pharmaceuticals said on Tuesday the U.S. Food and Drug Administration (FDA) will reconvene a meeting of its outside experts to review the company's application seeking approval for its amyotrophic lateral sclerosis (ALS) treatment. A panel of outside advisers to the... |
0 Comments
Leave a Reply. |
NewsMaxA conservative American news and opinion website founded by Christopher Ruddy in 1998 & operated by Newsmax Media. Archives
June 2023
Categories |